QUNR [Qunar Cayman Islands] CORRESP: New York Menlo Park Washington DC São Paulo

[New York Menlo Park Washington DC São Paulo London Paris Madrid Tokyo Beijing Hong Kong Li He Davis Polk & Wardwell LLP 2201 China World Office 2 1 Jian Guo Men Wai Avenue Chaoyang District Beijing 100004 86 10 8567 5005 tel 86 10 8567 5105 fax li.he@davispolk.com October 3, 2013 Re: Qunar Cayman Islands Limited Registration Statement on Form]

QUNR [Qunar Cayman Islands] F-1/A: CALCULATION OF REGISTRATION FEE Title of Each Class

[CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered (1) (2) Proposed Maximum (4) Amount Of Class B Ordinary shares, par value US$0.001 per share (3) US$125,000,000 US$17,050 (1) (2) (3) American depositary shares issuable upon deposit of the Class B ordinary shares registered hereby will be registered under a separate registration statement on Form F-6] [Business Cooperation Framework Agreement BUSINESS COOPERATION FRAMEWORK AGREEMENT Agreement (a) Qunar Qunar Cayman Islands Limited, a Cayman Islands exempted company (“ (b) Baidu Baidu, Inc., a Cayman Islands exempted company (“ Parties Party Qunar and Baidu, are hereinafter collectively referred to as the “ W I T N E S S E T H: Whereas, the Parties agree to further] [Consent of Independent Registered Public Accounting Firm We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 12, 2013, in Amendment No. 1 to the Registration Statement (Form F-1 No. 333-191459) and related Prospectus of Qunar Cayman Islands Limited for the registration of its ordinary shares. Beijing, People’s Republic]

HNP [HUANENG POWER INTERNATIONAL] 6-K: This Form 6-K consists of: DATE OF MEETING

[This Form 6-K consists of: DATE OF MEETING OF THE BOARD OF DIRECTORS AND PAYMENT OF 2012 FINAL DIVIDEND “ Board ” “ Company ” The board of directors (the In addition, the Board confirms that the cheques representing payment of the 2012 final dividend of RMB0.21 (tax inclusive) (equivalent to HK$0.259682) per share (net of enterprise income tax and]

By | 2016-03-30T11:18:39+00:00 October 3rd, 2013|Categories: Chinese Stocks, HNP, Webplus ver|Tags: , , , , , |0 Comments

CSIQ [Canadian Solar] 6-K: Canadian Solar Completes the Sale of Two Solar

[Canadian Solar Completes the Sale of Two Solar Power Plants to TransCanada GUELPH, Ontario, October 2, 2013 — Canadian Solar Inc. (the “Company”, or “Canadian Solar”) (NASDAQ: CSIQ), one of the world’s largest solar power companies, today announced that its wholly owned subsidiary, Canadian Solar Solutions Inc., has completed the sale of two solar power plants, Brockville 2 and Burritts] [FORM 6-K CANADIAN SOLAR INC. No. 199 Lushan Road Suzhou New District Suzhou, Jiangsu 215129 People’s Republic of China Form 20-F x Form 40-F o o o CANADIAN SOLAR INC. Form 6-K TABLE OF CONTENTS]

By | 2016-03-16T07:03:34+00:00 October 3rd, 2013|Categories: Chinese Stocks, CSIQ, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] CORRESP: October 2, 2013 John Reynolds Re: China Cord

[October 2, 2013 John Reynolds Re: China Cord Blood Corporation Registration Statement on Form F-3 Filed September 12, 2013 File No. 333-191121 Dear Mr. Reynolds: We hereby provide responses to comments issued on September 26, 2013 (the “Staff’s Letter”) regarding the Registration Statement on Form F-3 (File No. 333-191121)(the “F-3”) of China Cord Blood Corporation (the “Company”). In order to]

By | 2016-02-29T13:12:40+00:00 October 2nd, 2013|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

SIMO [Silicon Motion Technology] 6-K: Silicon Motion Announces Quarterly Dividend Taipei, Taiwan, October

[Silicon Motion Announces Quarterly Dividend Taipei, Taiwan, October 1, 2013 – Silicon Motion Technology Corporation (NasdaqGS: SIMO) (“Silicon Motion” or the “Company”), a global leader in designing and marketing NAND flash controllers for solid state storage devices and specialty RF IC solutions for mobile devices, announces today its next quarterly cash dividend. The Board of Directors of the Company has] [Press Release issued by the Company on October 1, 2013. ILICON OTION ECHNOLOGY ORPORATION S]

By | 2016-03-14T18:31:51+00:00 October 2nd, 2013|Categories: Chinese Stocks, SIMO, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Announces Fiscal Year 2013 Financial Results September

[TPI Announces Fiscal Year 2013 Financial Results September 27, 2013 Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the fiscal year 2013. Fiscal Year 2013 Ended June 30, 2013 Financial Highlights: · Revenue was $67.5 million compared] [Tianyin Pharmaceutical Inc. Fiscal Year 2013 Annual Financial Results Conference Call September 27, 2013 Operator James Tong - Chief Financial Officer. Financial highlights of Fiscal year 2013 ended June 30, 2013: Revenue totaled $67.5 million compared with $69.6 million in fiscal year 2012, a decrease of 3% year-over-year. Operating income was $9.3 million, compared with $8.5 million in fiscal year] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT September 27, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-27T18:11:14+00:00 October 2nd, 2013|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] CORRESP: October 2, 2013 John Reynolds Re: Chinard Bloodrporation

[October 2, 2013 John Reynolds Re: Chinard Bloodrporation Registration Statement on Form F-3 Filed September 12, 2013 File No. 333-191121 Dear Mr. Reynolds: We hereby provide responses tomments issued on September 26, 2013 (the Staffs Letter) regarding the Registration Statement on Form F-3 (File No. 333-191121)(the F-3) of Chinard Bloodrporation (thempany).]

By | 2016-02-04T15:43:36+00:00 October 2nd, 2013|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar